As artificial intelligence (AI) has become widely accessible, physicians and patients increasingly turn to AI for personal and professional uses. Whether or not you use AI in your practice, other physicians use it in ways that affect you and your patients, and so do cybercriminals. It is incumbent upon plastic surgeons and their staff to educate themselves about the potential advantages of AI, as well as potential medical and legal liabilities related to it. This article highlights the ways AI is increasingly employed in plastic surgical practice, discusses potential liabilities plastic surgeons (even those not actively using AI) should be aware of, and proposes risk-reduction strategies to safeguard patients, plastic surgeons, and practices.

Facial hollowing, skin laxity, and more prominent folds are increasingly reported during weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The term 'Ozempic face' can imply a drug-specific adverse effect, although similar changes occur after other forms of substantial weight loss. This review examines the clinical evidence, proposed mechanisms, and implications for aesthetic care. PubMed, Embase, Web of Science, and Google Scholar were searched for January 2014 through August 2026. Selection was reported using PRISMA 2020 where applicable, followed by narrative synthesis. Of 958 records, 46 reports were included. Serial imaging in 20 patients showed a median 9% reduction in midfacial volume, with greater loss in superficial than deep compartments (11% vs 7%). Regression estimated approximately 7% total midfacial volume loss per 10 kg lost. A FACE-Q short-form has been validated, and a survey of 1,226 participants found more reports of facial volume loss and laxity with greater percentage weight loss. Post-bariatric studies also describe facial deflation and increased apparent age, particularly in older patients and after larger losses. Current evidence favors weight-loss-associated deflation superimposed on baseline anatomy and aging. The independent effect of weight-loss rate and the modifying roles of menopause and hormone therapy remain uncertain. Aesthetic treatment evidence is limited and largely uncontrolled.